CAS 431996-53-1

Formule : C18H18ClN3O3

InChI : InChI=1S/C18H18ClN3O3/c1-13-2-3-14(12-17(13)19)18(23)21-10-8-20(9-11-21)15-4-6-16(7-5-15)22(24)25/h2-7,12H,8-11H2,1H3

Code InChI : PNECWWUOUHGWQG-UHFFFAOYSA-N

SMILES : CC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC=C(C=C3)[N+](=O)[O-])Cl

1-(3-chloro-4-methylbenzoyl)-4-(4-nitrophenyl)piperazine

CAS : 431996-53-1

Formule : C₁₈H₁₈ClN₃O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 359.8068

Ref: IN-DA00DLZK

Filastatin

CAS : 431996-53-1

Filastatin

Formule : C₁₈H₁₈ClN₃O₃

Degré de pureté : ≥98%

Masse moléculaire : 359.81

Ref: 54-BUP15623

Filastatin

CAS : 431996-53-1

Filastatin is a long-lasting inhibitor of Candida albicans filamentation, and has potent antifungal effect.

Formule : C₁₈H₁₈ClN₃O₃

Degré de pureté : 99.64%

Couleur et forme : Yellow Solid

Masse moléculaire : 359.81

Ref: TM-T8536

(3-Chloro-4-methylphenyl)(4-(4-nitrophenyl)piperazin-1-yl)methanone

CAS : 431996-53-1

Formule : C₁₈H₁₈ClN₃O₃

Degré de pureté : 98%

Masse moléculaire : 359.81

Ref: 10-F547712

Filastatin

CAS : 431996-53-1

Filastatin is a protein that acts as a tumor inhibitor, inducing apoptosis in cancer cells. It has been isolated from human and Chinese urine and is known to be structurally similar to the bacterial surfactin. Filastatin inhibits kinases, which are essential for cell division, and has been shown to be an effective anticancer agent in preclinical studies. This protein analog has potential for use in cancer therapy due to its ability to selectively target cancer cells while sparing normal cells. Its mechanism of action involves the activation of caspase-3, a key enzyme involved in programmed cell death. Filastatin represents a promising new avenue for the development of novel anticancer drugs with fewer side effects than traditional chemotherapy agents.

Formule : C₁₈H₁₈ClN₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 359.8 g/mol

Ref: 3D-GSA99653